Find your path to Eric
27 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.
Noubar AfeyanunlockedEric: together at Joule Unlimited, Inc. (2010–2014)
×3Eric: together at Antheia, Inc.
Eric: together at Progenity, Inc.
Eric: together at Biora Therapeutics
About
Eric d'Esparbes is Chief Financial Officer at Antheia, Inc. He previously served as interim CEO of the public companies Progenity in 2021 and Innoviva in 2018, and has held financial leadership roles across the pharmaceutical, biotech, diagnostics, and energy industries in Canada, Asia, and the United States. His experience includes managing IPO processes, capital raising, and reporting under SEC, US GAAP, and IFRS standards, as well as FDA and EMA regulatory environments.
Chief Financial Officer at Antheia, Inc.
Intro paths
→
In turn, Eric can intro founders to Antheia, Inc.'s investors below.
Antheia, Inc.'s investors · 5
Co-founders at Antheia, Inc.
CD
Christina D. SmolkeExecutive Officer, Director
CS
Christina SmolkeCo-Founder & CEO
KH
Kristy HawkinsCo-Founder & CSO
Experience
- Antheia, Inc.Chief Financial Officercurrent2025 — presentMenlo Park, California, United States
- CFOChief Financial Officer2025
- Biora TherapeuticsChief Financial Officer2022 — 2025San Diego, California, United States
- Progenity, Inc.Chief Financial Officer2019 — 2022Greater San Diego Area
- Progenity, Inc.Interim CEO2021San Diego, California, United States
- InnovivaSenior Vice President & Chief Financial Officer2014 — 2018San Francisco Bay Area
- InnovivaPrincipal Executive Officer & Chief Financial Officer2018San Francisco Bay Area
- Joule Unlimited, Inc.Senior Vice President - Chief Financial Officer2010 — 2014
- AEI Services LLCVice President Finance2010
- AEIChief Financial Officer - Asia2007 — 2010
- Meiya Power CompanyChief Financial Officier1999 — 2007
- Hydro QuébecDirector Project Finance - HQ International1993 — 1999
Skills & more
PresentationsOperational StrategyPresentation SkillsCoachingRevenue AnalysisP&L OperationsHealthcareForecastingHealthcare IndustryPEEBITDAPerformance Metrics
+12 more
Financial LeadershipFinancial StatementsFinancial PlanningAuditingCash FlowCapital AllocationQuantitative AnalyticsBudgetingStrategyOperational ExcellenceDecision-MakingSEC ComplianceFrom Eric's professional profile.
Frequently asked questions
- Who is Eric d'Esparbes?
- Eric d'Esparbes is Chief Financial Officer at Antheia, Inc. He previously served as interim CEO of the public companies Progenity in 2021 and Innoviva in 2018, and has held financial leadership roles across the pharmaceutical, biotech, diagnostics, and energy industries in Canada, Asia, and the United States. His experience includes managing IPO processes, capital raising, and reporting under SEC, US GAAP, and IFRS standards, as well as FDA and EMA regulatory environments.
- Where does Eric d'Esparbes work?
- Eric d'Esparbes is Chief Financial Officer at Antheia, Inc..
Shared employers
Also worked at Antheia, Inc.7
Jean SiniGeneral Partner at Partech VenturesJeff KarrasGeneral Partner at America's Frontier FundKristy HawkinsCo-Founder & CSO at Antheia, Inc.Zack McGaheyChief Operating Officer at Antheia, Inc.Heidi PucelChief People Officer at Antheia, Inc.Aaron CravensExecutive Officer at Revel Pharmaceuticals
+ 1 more
